The biotech segment has been growing well surpassing all expectations until Monday when shares slipped significantly. The NASDAQ Biotechnology Index ^NBI and NYSE ARCA BIOTECH INDEX ^BTK had gained 16.7% and 18.7%, respectively, til Apr 24 but both declined more than 4% on Monday after disappointing news from several biotech companies.Just when news of several mergers & acquisitions, product approvals […]
Benchmarks ended the first trading session of the week in the red led by losses in biotech shares. Meanwhile, investors refrained from placing big bets ahead of the Federal Reserve meeting, which begins today. Investors also kept an eye on first quarter earnings results.For a look at the issues currently facing the markets, make sure to read today’s Ahead of […]
Benchmarks ended higher on Wednesday following the prospect of Visa’s potential access to China, McDonald’s turnaround plans and upbeat housing data. Broad based gains among technology shares also had a positive impact on the markets. Meanwhile, investors continued to assess a mixed bag of corporate earnings results.For a look at the issues currently facing the markets, make sure to read […]
Benchmarks ended higher on Monday following China’s stimulus measures and upbeat earnings results. China’s central bank’s announcement that it would trim its reserve requirement ratio to boost lending and combat slow economic growth was welcomed by investors. Meanwhile, positive first quarter earnings results from Morgan Stanley, Halliburton and Hasbro also added to the bullish sentiment.For a look at the issues […]
Benchmarks finished mostly in the green on Tuesday, banking on gains in energy shares which were powered by a rise in oil prices. However, the Nasdaq settled in the red due to overall weakness in the technology sector. Meanwhile, investors remained focused on mixed earnings results and weaker than expected retail sales.For a look at the issues currently facing the […]
Benchmarks ended in the red for the fourth-straight session after escalating tensions in the Middle-East following an air strike in Yemen dampened investor sentiment. Additionally, the crisis in Yemen drove oil prices higher on Thursday on concerns that it may lead to reduction in oil supply. However, upbeat initial claims data limited some of the day’s losses. The S&P 500 […]
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
Recently, investors have begun to move away from sectors which offered higher dividends at lower risk towards companies. Funds are now being allocated to areas which offer growth at the cost of higher risk. This essentially signifies a move from sectors such as utilities and real estate to the likes of consumer discretionary financials and biotechnology stocks.http://www.zacks.com/stock/news/110282/3-top-ranked-biotech-mutual-funds-surging-higher
Continue reading –
3 Top Ranked […]
Benchmarks suffered huge losses on Tuesday as rate hike fears strengthened the U.S. dollar to a multi-year high against major currencies including the euro. Last week’s strong U.S. job numbers injected fears among investors that the Fed may raise interest rate sooner-than-expected. Moreover, stronger dollar had a negative impact on oil prices yesterday. The blue-chip index witnessed its biggest one-day […]
